Cargando…
Evaluating Antitumor Activity of Kiatomab by Targeting Cancer Stem Cell-Specific KIAA1114 Antigen in Mice
A full-length translational product of the trophinin gene, KIAA1114, is a distinctive marker of cancer stem cells in human hepatocellular carcinoma, and a mAb, Kiatomab, is specific to KIAA1114 antigen. In this study, we addressed the therapeutic potential of Kiatomab for treating both metastatic an...
Autores principales: | Kim, Sae Won, Park, Han Wook, Kim, Hyekang, Lee, Seungwon, Choi, So Young, Park, Yunji, Lee, Seung-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943170/ https://www.ncbi.nlm.nih.gov/pubmed/31921473 http://dx.doi.org/10.4110/in.2019.19.e43 |
Ejemplares similares
-
KIAA1114, a full-length protein encoded by the trophinin gene, is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypes
por: Kim, Sae Won, et al.
Publicado: (2014) -
TRAF6 Distinctly Regulates Hematopoietic Stem and Progenitors at Different Periods of Development in Mice
por: Kim, Hyekang, et al.
Publicado: (2018) -
Altered Gut Microbiota Composition in Rag1-deficient Mice Contributes to Modulating Homeostasis of Hematopoietic Stem and Progenitor Cells
por: Kwon, Ohseop, et al.
Publicado: (2015) -
Niche-specific MHC II and PD-L1 regulate CD4(+)CD8αα(+) intraepithelial lymphocyte differentiation
por: Moon, Sookjin, et al.
Publicado: (2021) -
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8(+) tumor-infiltrating lymphocytes
por: You, Gihoon, et al.
Publicado: (2021)